Dr Lalchandani Labs Limited Stock

Equities

DLCL6

INE871Z01013

Healthcare Facilities & Services

Market Closed - Bombay S.E. 06:00:51 2024-04-24 am EDT 5-day change 1st Jan Change
20.84 INR -0.05% Intraday chart for Dr Lalchandani Labs Limited -0.05% -1.84%
Sales 2022 113M 1.35M Sales 2023 50.4M 604K Capitalization 123M 1.48M
Net income 2022 9M 108K Net income 2023 -15M -180K EV / Sales 2022 1.41 x
Net Debt 2022 16.11M 193K Net Debt 2023 31.92M 383K EV / Sales 2023 3.08 x
P/E ratio 2022
15.3 x
P/E ratio 2023
-7.87 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 21.35%
More Fundamentals * Assessed data
Dynamic Chart
Dr Lalchandani Labs Limited Announces Resignation of Karan Kumar as Company Secretary and Compliance Officer CI
Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer CI
Dr Lalchandani Labs Limited Approves Resignation of Monika Joshi as Company Secretary and Compliance Officer CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Dr Lalchandani Labs Limited Announces Resignation of Archana Jha from the Office of Company Secretary CI
Dr Lalchandani Labs Limited Appoints Monika Joshi as Company Secretary and Compliance Officer, Effective August 27, 2023 CI
Dr Lalchandani Labs Limited Announces Resignation of Archana R Jha as Company Secretary CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Dr Lalchandani Labs Limited Announces Management Changes CI
Dr Lalchandani Labs Limited Appoints Archana Jha as Company Secretary & Compliance Officer CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2022 CI
Dr Lalchandani Labs Limited Announces Resignation of CS Swati Poddar as Company Secretary and Compliance Officer CI
Dr Lalchandani Labs Limited Resumes in Full Capacity At the Lab in Punjabi Bagh CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Dr Lalchandani Labs to Provide Diagnostic Services in Delhi, India, as Part of New Deal MT
More news
1 day-0.05%
1 week-0.05%
Current month+32.65%
1 month+32.65%
3 months-1.00%
6 months-28.63%
Current year-1.84%
More quotes
1 week
19.81
Extreme 19.81
20.84
1 month
16.49
Extreme 16.49
21.90
Current year
15.68
Extreme 15.68
24.86
1 year
15.68
Extreme 15.68
35.00
3 years
15.68
Extreme 15.68
52.50
5 years
6.75
Extreme 6.75
52.50
10 years
6.75
Extreme 6.75
52.50
More quotes
Managers TitleAgeSince
Founder 38 16-12-31
Founder 69 16-12-31
Director of Finance/CFO 37 17-08-01
Members of the board TitleAgeSince
Founder 69 16-12-31
Founder 38 16-12-31
Director of Finance/CFO 37 17-08-01
More insiders
Date Price Change Volume

Delayed Quote Bombay S.E., April 24, 2024 at 06:00 am EDT

More quotes
Dr Lalchandani Labs Limited is an India-based company, which is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. Through its integrated network, the Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The Company has its own blood banking services through its sister concern CPC blood bank. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
More about the company